Lyons, France

Didier Negre


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Didier Negre in Lentiviral Vector Technology

Introduction

Didier Negre is a notable inventor residing in Lyons, France, recognized for his advancements in the field of genetic engineering and virology. With a significant contribution reflected in one patent, his work focuses on enhancing the efficacy of gene delivery systems through improved chimeric glycoproteins and lentiviral vectors.

Latest Patents

Negre's patent, titled "Chimeric glycoproteins and pseudotyped lentiviral vectors," outlines a groundbreaking invention that introduces improved chimeric glycoproteins and lentiviral vectors pseudotyped with these glycoproteins. His invention details methods and compositions for creating these glycoproteins and vectors while also improving the processes for in vitro and in vivo transduction of cells. The enhanced chimeric glycoproteins encode the extracellular and transmembrane domains of GALV or RD114 glycoproteins fused with the cytoplasmic tail of MLV-A glycoprotein, resulting in vectors with significantly higher titers compared to those using the parental glycoproteins. Additionally, the RD114/TR-pseudotyped vectors demonstrate superior concentration efficiency and resilience against inactivation by human and macaque sera. This innovation is particularly beneficial for in vivo gene transfer applications.

Career Highlights

Throughout his career, Didier Negre has collaborated with prominent institutions that reflect his commitment to research and innovation. He has worked with the Institut National de la Santé et de la Recherche Médicale and the Clayton Research Institute, contributing his expertise to various scientific endeavors.

Collaborations

Negre has had the opportunity to work with renowned professionals in the field, including Didier Trono and François-Loïc Cosset. These collaborations have further propelled advancements in lentiviral vector technology and gene therapy.

Conclusion

Didier Negre's contributions to the field of virology and genetic engineering are exemplified through his innovative patent on chimeric glycoproteins and lentiviral vectors. His work not only enhances current methodologies but also opens new avenues for in vivo gene transfer applications, showcasing the significant impact of his research in modern science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…